Immunic (IMUX) Stock Statistics & Valuation Metrics

Immunic has a market cap or net worth of $152.64M. The enterprise value is $100.66M.

Immunic has 130,464,830 shares outstanding. The number of shares has decreased by -2.65% in one year.

Immunic’s return on equity (ROE) is 14.56 and return on invested capital (ROIC) is 1693.37%.

The current PE Ratio of Immunic is ―. Immunic’s PEG ratio is 0.23.

In the last 12 months, Immunic had revenue of 0.00 and earned -97.17M in profits. Earnings per share was -0.62.

In the last 12 months, operating cash flow was -85.81M and capital expenditures -161.00K, giving a free cash flow of -85.97M billion.

Immunic pays an annual dividend of ―, resulting in a dividend yield of ―

Immunic upcoming earnings date is May 7, 2026, Before Open (Confirmed).

Immunic as a current ratio of 0.75, with Debt / Equity ratio of -10.25%

In the past 12 months, Immunic has paid 0.00 in taxes.

Immunic EV to EBITDA ratio is -8.41, with an EV/FCF ratio of -9.49.

Immunic has $15.48M in cash and marketable securities with $684.00K in debt, giving a net cash position of $14.80M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Immunic is $3.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy